secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO KEY INTERNATIONAL INC (BKYI)
CIK:        0001019034
Form:       8-K
Filed at:   2023-08-15T23:59:59+00:00
Accession:  0001437749-23-023794
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BIO-key Q2 revenue flat at $1.9M; net loss narrows to $1.4M
-----------------------------------------------------------

- Q2 revenue $1.9M flat YoY; first-half revenue up 29% to $5.9M.
- Q2 gross margin improved to 69% from 63%; gross profit $1.3M up 8%.
- Q2 net loss narrowed to $1.4M from $1.7M; operating expenses down 10%.
- Signed $0.3M defense ministry order in early Q3; expanding EMEA partnerships.
- Management confident in FY2023 top-line growth and bottom-line improvements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1019034/000143774923023794/0001437749-23-023794-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1019034/000143774923023794/bkyi20230814_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-023794

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer